Hogan Lovells Cadwalader has advised Jazz Pharmaceuticals. Cooley has advised Actio Biosciences. Jazz Pharmaceuticals plc has entered into a definitive agreement to acquire Actio Biosciences, Inc....
Jazz Pharmaceuticals Announces $820 Million Acquisition of Actio Biosciences
Apnimed Secures $150 Million Debt Financing and Monetizes SASS Joint Venture Stake
Hogan Lovells has advised HealthCare Royalty Partners. Goodwin has advised Apnimed, Inc. Apnimed, Inc., a pharmaceutical company focused on developing oral therapies for obstructive sleep apnea...
DRI Healthcare Trust’s Acquisition Of XENPOZYME From HLS Therapeutics Inc.
Hogan Lovells has advised HLS Therapeutics Inc. on the deal. HLS Therapeutics Inc. (TSX: HLS) sold its royalty interest and milestone payment obligations in the global...